[artículo] 
inThe Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.10 (Octubre) . - pp. 1359-1365

Título :	Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder : A randomized trial
Tipo de documento:	texto impreso
Autores:	Alan I. Green, Autor ; Mary F. Brunette, Autor ; Ree Dawson, Autor
Fecha de publicación:	2020
Artículo en la página:	pp. 1359-1365
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Administración Oral, Alcoholismo, Agentes antipsicóticos, Entrevista psicológica, Risperidona, Risperidona, Esquizofrenia.
Resumen:	Alcohol use disorders worsen the course of schizophrenia. Although the atypical antipsychotic clozapine appears to decrease alcohol use in schizophrenia, risperidone does not. We have proposed that risperidone’s relatively potent dopamine D2 receptor blockade may partly underlie its lack of effect on alcohol use.
Link:	./index.php?lvl=notice_display&id=21886

[artículo] Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder : A randomized trial [texto impreso] / Alan I. Green, Autor ; Mary F. Brunette, Autor ; Ree Dawson, Autor . - 2020 . - pp. 1359-1365.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.10 (Octubre) . - pp. 1359-1365

Palabras clave:	Administración Oral, Alcoholismo, Agentes antipsicóticos, Entrevista psicológica, Risperidona, Risperidona, Esquizofrenia.
Resumen:	Alcohol use disorders worsen the course of schizophrenia. Although the atypical antipsychotic clozapine appears to decrease alcohol use in schizophrenia, risperidone does not. We have proposed that risperidone’s relatively potent dopamine D2 receptor blockade may partly underlie its lack of effect on alcohol use.
Link:	./index.php?lvl=notice_display&id=21886